Caplight Directory>Investors>CTI Life Sciences Fund>Ctisciences


CTI Life Sciences Fund

CTI Life Sciences Fund

Quebecctisciences.com

Overview

CTI Life Sciences Fund is a knowledge-driven boutique venture capital firm that aims to deliver strong results on investments in Life Sciences . Their mission is to catalyze emerging science, transform business objectives, and invest in scalable companies within Canada, the United States and Europe . They focus on pre-clinical and early clinical-stage therapeutics companies, with a secondary focus on mid-and growth-stage medtech opportunities and an exploratory focus on Healthcare Services and Healthcare IT .

Year Founded

2006

Portfolio Companies

8

Investments

CompanyDateStageLead
Kainova TherapeuticsFeb 2026Series BCo-investor
Aeovian PharmaceuticalsDec 2025Series BLead
Thryv TherapeuticsSep 2025Series BCo-investor
GlycomineApr 2025Series CLead
Find TherapeuticsSep 2024Convertible DebtCo-investor
View all investments

Key People

Laurence Rulleau

Managing Partner At CTI LSF III

Youssef Bennani

Managing Partner-CTI Life Sciences

Xin Hang

Principal

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersQuebec
Year Founded2006

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.